ABSI
Price
$10.21
Change
-$0.39 (-3.68%)
Updated
Jul 13 closing price
Capitalization
1.73B
35 days until earnings call
Intraday BUY SELL Signals
DNA
Price
$9.05
Change
-$0.04 (-0.44%)
Updated
Jul 13 closing price
Capitalization
591.19M
23 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABSI vs DNA

ABSI vs DNA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ABSI vs. DNA commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Buy and DNA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (ABSI: $10.21 vs. DNA: $9.05)
Brand notoriety: ABSI and DNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 27% vs. DNA: 53%
Market capitalization -- ABSI: $1.73B vs. DNA: $591.19M
ABSI [@Biotechnology] is valued at $1.73B. DNA’s [@Biotechnology] market capitalization is $591.19M. The market cap for tickers in the [@Biotechnology] industry ranges from $121.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileDNA’s FA Score has 1 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • DNA’s FA Score: 1 green, 4 red.
According to our system of comparison, DNA is a better buy in the long-term than ABSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 2 TA indicator(s) are bullish while DNA’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 2 bullish, 6 bearish.
  • DNA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DNA is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а -11.53% price change this week, while DNA (@Biotechnology) price change was -10.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.21%. For the same industry, the average monthly price growth was +7.25%, and the average quarterly price growth was +1806.27%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 18, 2026.

DNA is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (-3.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABSI($1.73B) has a higher market cap than DNA($591M). ABSI YTD gains are higher at: 192.550 vs. DNA (8.905). ABSI has higher annual earnings (EBITDA): -106.8M vs. DNA (-251.5M). DNA has more cash in the bank: 373M vs. ABSI (126M). ABSI has less debt than DNA: ABSI (4.42M) vs DNA (411M). DNA has higher revenues than ABSI: DNA (151M) vs ABSI (1.84M).
ABSIDNAABSI / DNA
Capitalization1.73B591M293%
EBITDA-106.8M-251.5M42%
Gain YTD192.5508.9052,162%
P/E RatioN/AN/A-
Revenue1.84M151M1%
Total Cash126M373M34%
Total Debt4.42M411M1%
TECHNICAL ANALYSIS
Technical Analysis
ABSIDNA
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 18 days ago
89%
Bullish Trend 12 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signal:
Gain/Loss:
DNA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FYC121.80N/A
N/A
First Trust Small Cap Gr AlphaDEX® ETF
PRFD50.81-0.13
-0.26%
PIMCO Preferred and Cp Sec Act Exc-Trd
SAA36.07-0.33
-0.91%
ProShares Ultra SmallCap600
BLOX14.05-0.52
-3.57%
Nicholas Crypto Income ETF
COZX16.83-1.33
-7.32%
Tradr 2X Long CORZ Daily ETF